Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 79,100 | 906,800 | 827,000 | 413,200 | 83,200 |
| Depreciation Amortization | 25,900 | 199,400 | 173,700 | 117,300 | 58,600 |
| Income taxes - deferred | 2,800 | -47,500 | -83,700 | -189,300 | 13,200 |
| Accounts receivable | 16,500 | -77,100 | -43,100 | -213,400 | -130,900 |
| Accounts payable and accrued liabilities | -18,100 | -14,100 | -45,500 | -6,000 | -19,200 |
| Other Working Capital | -163,800 | -140,000 | -91,400 | -358,300 | -375,100 |
| Other Operating Activity | 6,000 | -373,000 | -419,600 | 243,000 | 163,900 |
| Operating Cash Flow | $-51,600 | $454,500 | $317,400 | $6,500 | $-206,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23,100 | 1,057,100 | 1,048,300 | -92,800 | -35,800 |
| Net Acquisitions | -71,700 | -45,600 | -45,600 | -39,600 | -39,000 |
| Sale Of Investment | 2,000 | 22,500 | 19,800 | 12,200 | 2,100 |
| Other Investing Activity | 6,000 | -115,800 | 0 | 0 | 0 |
| Investing Cash Flow | $-86,800 | $918,200 | $1,022,500 | $-120,200 | $-72,700 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -8,500 | -34,400 | -38,900 | 144,900 | 281,100 |
| Debt Issued | N/A | 500,000 | 0 | 0 | N/A |
| Debt Repayment | 0 | -2,440,900 | -1,640,600 | -590,600 | -590,600 |
| Common Stock Issued | 45,200 | 102,300 | 67,500 | 38,700 | 20,700 |
| Dividend Paid | -32,300 | -118,600 | -89,000 | -59,400 | -30,100 |
| Other Financing Activity | 3,100 | -10,900 | -8,700 | 2,000 | 800 |
| Financing Cash Flow | $7,500 | $-2,002,500 | $-1,709,700 | $-464,400 | $-318,100 |
| Exchange Rate Effect | 1,100 | -16,600 | -19,000 | 800 | 1,600 |
| Beginning Cash Position | 218,300 | 811,500 | 811,500 | 811,500 | 811,500 |
| End Cash Position | 88,500 | 218,300 | 412,400 | 229,800 | 217,500 |
| Net Cash Flow | $-129,800 | $-593,200 | $-399,100 | $-581,700 | $-594,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,600 | 454,500 | 317,400 | 6,500 | -206,300 |
| Capital Expenditure | -23,400 | -218,500 | -161,600 | -98,000 | -37,300 |
| Free Cash Flow | -75,000 | 236,000 | 155,800 | -91,500 | -243,600 |